Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page

Roche Holding AG ADR Stock

Price
Target price
€35.85

€35.85

0.400%
0.1421
0.400%
€42.50
 
06.06.25 / Tradegate WKN: 891106 / Symbol: RHHBY / Name: Roche / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...
Your prediction
Pros and Cons of Roche Holding AG ADR in the next few years
Wizard

Roche Holding AG ADR Stock

Roche Holding AG ADR gained 0.400% compared to yesterday.
Our community is currently high on Roche Holding AG ADR with 3 Buy predictions and 1 Sell predictions.
With a target price of 42 € there is a slightly positive potential of 17.16% for Roche Holding AG ADR compared to the current price of 35.85 €.
So far the community has only identified positive things for Roche Holding AG ADR stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
What does Roche do?

Pros and Cons of Roche Holding AG ADR in the next few years

Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

Performance of Roche Holding AG ADR vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Roche Holding AG ADR 0.400% 1.009% 0.163% 16.643% 7.693% -7.232% -5.809%
Novartis AG ADR 0.490% 1.961% 6.996% 6.776% 10.169% 25.000% 35.948%
Bayer AG ADR 0.780% 8.333% 10.169% -10.345% 31.048% -60.606% -60.366%
Novo Nordisk A/S ADR 3.310% 3.968% 12.350% -50.000% -21.651% -37.915% 13.913%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-11-10

Roche Holding AG (RHHBY), a multinational healthcare company based in Switzerland, stands strong with its broad and diversified portfolio. A closer look into Roche's financial statements prominently reveals a robust business model underpinned by substantial revenues and a profitable margin.

Observing Roche's income statements over the past three years, the figures showcase an impressive gross profit with a steady upward trend. This consistency strongly indicates a robust operating model and proficient managerial efficiency. With increasing net income, the company seems to have experienced notable business and financial growth, reinforcing the credibility of the investment.

Roche also earns recognition for its significant investment in research and development, crucial for pharmaceutical companies. The data reveals a substantial annual expenditure, reflecting Roche's commitment to future growth and revolutionizing pharmaceutical breakthroughs, leading to a sustainable competitive advantage.

Show more

Comments

Roche Holding AG (OTCMKTS: RHHBY) was upgraded by analysts at Sanford C. Bernstein to a "strong-buy" rating.
Ratings data for RHHBY provided by MarketBeat
Show more

Sanford C. Bernstein 
0
Report Share
01.02.25 Buy -3.93%

Roche Holding AG (OTCMKTS: RHHBY) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating.
Ratings data for RHHBY provided by MarketBeat
Show more

Bank of America Co. 
0
Report Share
13.09.24 Buy 0.71%

Roche Holding AG (OTCMKTS: RHHBY) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "sell" rating.
Ratings data for RHHBY provided by MarketBeat
Show more

Deutsche Bank Aktiengesellschaft 
0
Report Share
13.09.24 Sell 0.71%
Show more
Not a member yet? Sign up for free!

News

Why Weight-Loss Developer Stocks Tumbled on Tuesday: https://g.foolcdn.com/editorial/images/818224/healthcare-professional-inspecting-charts.jpg
Why Weight-Loss Developer Stocks Tumbled on Tuesday

Makers of weight-loss drugs, the hottest segment of the pharmaceutical market just now, weren't looking so hot on the stock exchange Tuesday. A pronouncement from President Trump about the category

TheMotleyFool 
0 14.05.25
3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.: https://www.marketbeat.com/logos/articles/med_20250425125134_3-top-big-pharma-stocks-investing-over-100-billion.jpg
3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.

Amid recession worries and tumbling markets; President Trump's tariffs are still helping the U.S. economy achieve key wins. Many huge corporations have announced plans to invest billions in U.S

MarketBeat 
0 28.04.25
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today: https://g.foolcdn.com/editorial/images/814256/red-stamp-reads-tariffs.jpg
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today

Just like the rest of the stock market, pharmaceutical stocks are in a funk approaching the midweek mark, and it's looking like things might be about to get even worse for this particular pocket of

TheMotleyFool 
0 09.04.25